Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia

Hypertriglyceridemia increases risk for atherosclerotic cardiovascular disease and may contribute to atherosclerosis by changing circulating monocyte phenotypes. High-dose n-3 polyunsaturated fatty acids reduce blood triglyceride levels. Effects of triglyceride-lowering therapy on monocyte phenotype...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical lipidology 2017-11, Vol.11 (6), p.1361-1371
Hauptverfasser:	Dai Perrard, Xiao-Yuan, Lian, Zeqin, Bobotas, George, Dicklin, Mary R., Maki, Kevin C., Wu, Huaizhu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Atherosclerosis Atherosclerosis - blood Atherosclerosis - drug therapy Atherosclerosis - pathology CD11c Antigen - blood CD36 Antigens - blood Docosapentaenoic acid Drug Combinations Eicosapentaenoic acid Eicosapentaenoic Acid - administration & dosage Fatty Acids, Omega-3 - administration & dosage Fatty Acids, Unsaturated - administration & dosage Female Flow Cytometry Humans Hypertriglyceridemia Hypertriglyceridemia - blood Hypertriglyceridemia - drug therapy Hypertriglyceridemia - pathology Male Middle Aged Monocytes Monocytes - drug effects n-3 polyunsaturated fatty acids Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!